ID   MYCT_HUMAN              Reviewed;         648 AA.
AC   Q96QE2; Q17S07;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 3.
DT   09-APR-2025, entry version 186.
DE   RecName: Full=Proton myo-inositol cotransporter {ECO:0000305};
DE            Short=H(+)-myo-inositol cotransporter {ECO:0000303|PubMed:11500374};
DE            Short=Hmit {ECO:0000303|PubMed:11500374};
DE   AltName: Full=H(+)-myo-inositol symporter {ECO:0000303|PubMed:11500374};
DE   AltName: Full=Solute carrier family 2 member 13;
GN   Name=SLC2A13 {ECO:0000312|HGNC:HGNC:15956};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=11500374; DOI=10.1093/emboj/20.16.4467;
RA   Uldry M., Ibberson M., Horisberger J.-D., Chatton J.-Y., Riederer B.M.,
RA   Thorens B.;
RT   "Identification of a mammalian H(+)-myo-inositol symporter expressed
RT   predominantly in the brain.";
RL   EMBO J. 20:4467-4477(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-648.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-645, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-645, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6]
RP   INDUCTION.
RX   PubMed=21679696; DOI=10.1016/j.bbrc.2011.06.001;
RA   Kage-Nakadai E., Uehara T., Mitani S.;
RT   "H+/myo-inositol transporter genes, hmit-1.1 and hmit-1.2, have roles in
RT   the osmoprotective response in Caenorhabditis elegans.";
RL   Biochem. Biophys. Res. Commun. 410:471-477(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-645, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-645, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: H(+)-myo-inositol cotransporter (PubMed:11500374). Can also
CC       transport related stereoisomers (PubMed:11500374).
CC       {ECO:0000269|PubMed:11500374}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=myo-inositol(out) + H(+)(out) = myo-inositol(in) + H(+)(in);
CC         Xref=Rhea:RHEA:60364, ChEBI:CHEBI:15378, ChEBI:CHEBI:17268;
CC         Evidence={ECO:0000269|PubMed:11500374};
CC   -!- INTERACTION:
CC       Q96QE2; P78329: CYP4F2; NbExp=3; IntAct=EBI-18082698, EBI-1752413;
CC       Q96QE2; Q96CV9: OPTN; NbExp=3; IntAct=EBI-18082698, EBI-748974;
CC       Q96QE2; Q04941: PLP2; NbExp=3; IntAct=EBI-18082698, EBI-608347;
CC       Q96QE2; Q9NPQ8-4: RIC8A; NbExp=3; IntAct=EBI-18082698, EBI-9091816;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11500374};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11500374}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the brain.
CC       {ECO:0000269|PubMed:11500374}.
CC   -!- INDUCTION: Induced by hyperosmotic stress.
CC       {ECO:0000269|PubMed:21679696}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:11500374}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Sugar
CC       transporter (TC 2.A.1.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI17118.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAI17120.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAC51116.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ315644; CAC51116.1; ALT_INIT; mRNA.
DR   EMBL; BC117117; AAI17118.1; ALT_INIT; mRNA.
DR   EMBL; BC117119; AAI17120.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8736.2; -.
DR   RefSeq; NP_443117.3; NM_052885.4.
DR   AlphaFoldDB; Q96QE2; -.
DR   SMR; Q96QE2; -.
DR   BioGRID; 125286; 14.
DR   IntAct; Q96QE2; 9.
DR   STRING; 9606.ENSP00000280871; -.
DR   TCDB; 2.A.1.1.25; the major facilitator superfamily (mfs).
DR   GlyCosmos; Q96QE2; 3 sites, No reported glycans.
DR   GlyGen; Q96QE2; 4 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; Q96QE2; -.
DR   PhosphoSitePlus; Q96QE2; -.
DR   SwissPalm; Q96QE2; -.
DR   BioMuta; SLC2A13; -.
DR   DMDM; 294862502; -.
DR   jPOST; Q96QE2; -.
DR   MassIVE; Q96QE2; -.
DR   PaxDb; 9606-ENSP00000280871; -.
DR   PeptideAtlas; Q96QE2; -.
DR   ProteomicsDB; 77861; -.
DR   Pumba; Q96QE2; -.
DR   Antibodypedia; 1512; 148 antibodies from 22 providers.
DR   DNASU; 114134; -.
DR   Ensembl; ENST00000280871.9; ENSP00000280871.4; ENSG00000151229.13.
DR   GeneID; 114134; -.
DR   KEGG; hsa:114134; -.
DR   MANE-Select; ENST00000280871.9; ENSP00000280871.4; NM_052885.4; NP_443117.3.
DR   UCSC; uc010skm.2; human.
DR   AGR; HGNC:15956; -.
DR   CTD; 114134; -.
DR   DisGeNET; 114134; -.
DR   GeneCards; SLC2A13; -.
DR   HGNC; HGNC:15956; SLC2A13.
DR   HPA; ENSG00000151229; Tissue enhanced (brain, parathyroid gland).
DR   MIM; 611036; gene.
DR   neXtProt; NX_Q96QE2; -.
DR   OpenTargets; ENSG00000151229; -.
DR   PharmGKB; PA38066; -.
DR   VEuPathDB; HostDB:ENSG00000151229; -.
DR   eggNOG; KOG0254; Eukaryota.
DR   GeneTree; ENSGT00940000155870; -.
DR   HOGENOM; CLU_001265_30_5_1; -.
DR   InParanoid; Q96QE2; -.
DR   OMA; ETGWRWM; -.
DR   OrthoDB; 6339427at2759; -.
DR   PhylomeDB; Q96QE2; -.
DR   TreeFam; TF314916; -.
DR   PathwayCommons; Q96QE2; -.
DR   Reactome; R-HSA-429593; Inositol transporters.
DR   SignaLink; Q96QE2; -.
DR   BioGRID-ORCS; 114134; 17 hits in 1169 CRISPR screens.
DR   ChiTaRS; SLC2A13; human.
DR   GeneWiki; SLC2A13; -.
DR   GenomeRNAi; 114134; -.
DR   Pharos; Q96QE2; Tbio.
DR   PRO; PR:Q96QE2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q96QE2; protein.
DR   Bgee; ENSG00000151229; Expressed in lateral nuclear group of thalamus and 182 other cell types or tissues.
DR   ExpressionAtlas; Q96QE2; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IBA:GO_Central.
DR   GO; GO:0097450; C:astrocyte end-foot; ISS:ARUK-UCL.
DR   GO; GO:0044297; C:cell body; IDA:ARUK-UCL.
DR   GO; GO:0071944; C:cell periphery; IDA:ARUK-UCL.
DR   GO; GO:0042995; C:cell projection; IDA:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0030426; C:growth cone; ISS:ARUK-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; ISS:ARUK-UCL.
DR   GO; GO:0031090; C:organelle membrane; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IPI:ARUK-UCL.
DR   GO; GO:0005365; F:myo-inositol transmembrane transporter activity; ISS:ARUK-UCL.
DR   GO; GO:0005366; F:myo-inositol:proton symporter activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:ARUK-UCL.
DR   GO; GO:0015798; P:myo-inositol transport; IDA:UniProtKB.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IGI:ARUK-UCL.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   GO; GO:0150104; P:transport across blood-brain barrier; NAS:ARUK-UCL.
DR   CDD; cd17360; MFS_HMIT_like; 1.
DR   FunFam; 1.20.1250.20:FF:000105; proton myo-inositol cotransporter isoform X1; 1.
DR   FunFam; 1.20.1250.20:FF:000177; proton myo-inositol cotransporter isoform X1; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 2.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR050814; Myo-inositol_Transporter.
DR   InterPro; IPR003663; Sugar/inositol_transpt.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   NCBIfam; TIGR00879; SP; 1.
DR   PANTHER; PTHR48020; PROTON MYO-INOSITOL COTRANSPORTER; 1.
DR   PANTHER; PTHR48020:SF12; PROTON MYO-INOSITOL COTRANSPORTER; 1.
DR   Pfam; PF00083; Sugar_tr; 2.
DR   PRINTS; PR00171; SUGRTRNSPORT.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 2.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
DR   PROSITE; PS00217; SUGAR_TRANSPORT_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Membrane; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..648
FT                   /note="Proton myo-inositol cotransporter"
FT                   /id="PRO_0000050456"
FT   TOPO_DOM        1..76
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        77..97
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        98..125
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        126..146
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        147..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        170..178
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        179..199
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        200..212
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        213..233
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        234..239
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        240..260
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        261..324
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        325..345
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        346..363
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        364..384
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        385..393
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        394..414
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        415..508
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        509..529
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        530..549
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        550..570
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        571..573
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        574..594
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        595..648
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHK1"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHK1"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHK1"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   CARBOHYD        433
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        458
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        485
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   648 AA;  70371 MW;  07B951E20A7F46EB CRC64;
     MSRKASENVE YTLRSLSSLM GERRRKQPEP DAASAAGECS LLAAAESSTS LQSAGAGGGG
     VGDLERAARR QFQQDETPAF VYVVAVFSAL GGFLFGYDTG VVSGAMLLLK RQLSLDALWQ
     ELLVSSTVGA AAVSALAGGA LNGVFGRRAA ILLASALFTA GSAVLAAANN KETLLAGRLV
     VGLGIGIASM TVPVYIAEVS PPNLRGRLVT INTLFITGGQ FFASVVDGAF SYLQKDGWRY
     MLGLAAVPAV IQFFGFLFLP ESPRWLIQKG QTQKARRILS QMRGNQTIDE EYDSIKNNIE
     EEEKEVGSAG PVICRMLSYP PTRRALIVGC GLQMFQQLSG INTIMYYSAT ILQMSGVEDD
     RLAIWLASVT AFTNFIFTLV GVWLVEKVGR RKLTFGSLAG TTVALIILAL GFVLSAQVSP
     RITFKPIAPS GQNATCTRYS YCNECMLDPD CGFCYKMNKS TVIDSSCVPV NKASTNEAAW
     GRCENETKFK TEDIFWAYNF CPTPYSWTAL LGLILYLVFF APGMGPMPWT VNSEIYPLWA
     RSTGNACSSG INWIFNVLVS LTFLHTAEYL TYYGAFFLYA GFAAVGLLFI YGCLPETKGK
     KLEEIESLFD NRLCTCGTSD SDEGRYIEYI RVKGSNYHLS DNDASDVE
//